---
document_datetime: 2023-09-21 19:49:20
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tamiflu-epar-all-authorised-presentations_en.pdf
document_name: tamiflu-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0553768
conversion_datetime: 2025-12-22 16:18:52.563605
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form        | Route of Administration   | Immediate Packaging       | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|----------------------------|---------------------------|---------------------------|---------------------------|-------------|
| EU/1/02/222/001  | Tamiflu           | 75 mg      | Capsule, hard              | Oral use                  | blister (PVC/PE/PVDC/alu) |                           | 10 capsules |
| EU/1/02/222/003  | Tamiflu           | 30 mg      | Capsule, hard              | Oral use                  | blister (PVC/PE/PVDC/alu) |                           | 10 capsules |
| EU/1/02/222/004  | Tamiflu           | 45 mg      | Capsule, hard              | Oral use                  | blister (PVC/PE/PVDC/alu) |                           | 10 capsules |
| EU/1/02/222/005  | Tamiflu           | 6 mg/ml    | Powder for oral suspension | Oral use                  | bottle (glass)            | 13 g                      | 1 bottle    |